OB protein: A hormonal controller of central neural networks mediating behavioral, metabolic and neuroendocrine responses

Endocrinology and Metabolism, Supplement

Volumn 4, Issue 2, 1997, Pages 81-102

  Arthur Campfield, L ^a   Smith, Françoise J ^a   Burn, Paul ^a  

^a Hoffman La Roche Department of Metabolic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

AUTONOMIC NERVOUS SYSTEM; BASAL METABOLIC RATE; BODY FAT; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; NERVE CELL NETWORK; NEUROENDOCRINE SYSTEM; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW;

EID: 0030832636     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Campfield LA, Smith FJ, Burn P. Genetics of Obesity. In: Adelman G, Smith B, editors. Encyclopedia of Neuroscience, 2nd edn. Amsterdam: Elsevier Science, 1997 in press.
2. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks. Horm. Metab. Res. 1996; 28: 619-632.
3. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc. Royal Soc. London. Series B 1953; 140: 578-592.
4. Campfield LA, Smith FJ, Burn P. OB protein, OB protein receptor, and the OB protein pathway. In: Weston LA, Savage LM, editors. Obesity: Advances in Understanding and Treatment. Southborough, MA: IBC Biomedical Library Series, International Business Communications, Inc., 1996: 1.3.1-1.3.31.
5. Campfield LA. The role of pharmacological agents in treatment of obesity. In: Weston LA, Savage LM, editors. Obesity: Advances in Understanding and Treatment. Southborough, MA: IBC Biomedical Library Series, International Business Communications, Inc., 1996: 4.4.1-4.4.32.
6. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Baur TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996; 334: 292-295.
7. Bjorntorp P, Brodoff BN, editors. Obesity. Philadelphia, PA: J. B. Lippincott, 1992.
8. Bouchard C, Perusse L. Genetics of obesity. Annu. Rev. Nutr 1993; 13: 337-354.
9. Thomas PR, editor. Weighing the Options: Criteria for the Evaluating Weight-Management Programs. Washington, D. C.: Food and Nutrition Board, Institute of Medicine, National Academy Press, 1995.
10. Chadwick DJ, Cardew G, editors. The Origins and Consequences of Obesity. Chichester: John Wiley and Sons Ltd, 1996. (Ciba Foundation Symposium 201).
11. Campfield LA. Treatment options and the maintenance of weight loss. In: Allison DB, Pi-Sunyer FX, editors. Obesity Treatment: Establishing Goals, Improving Outcomes, and Reviewing the Research Agenda. New York: Plenum Press, 1995: 93-95.
12. Bogardus C, Lillioja S, Ravussin E, Abbott W, Zawadzki JK, Young A. Familial dependence of the resting metabolic rate. N. Eng. J. Med. 1986; 315: 96-100.
13. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med. 1995; 232: 621-628.
14. Kaiyala KJ, Woods SC, Schwartz MW. New model for the regulation of energy balance and adiposity by the central nervous system. Am. J. Clin. Nutr. 1995; 62: 1123s-1134s.
15. Le Magnen J. Neurobiology of Feeding and Nutrition. San Diego, CA: Academic Press, 1992.
16. Campfield LA, Smith FJ. Systemic factors in the control of food intake: Evidence for patterns as signals. In: Stricker EM, editor. Handbook of Behavioral Neurobiology, Vol. 10, Neurobiology of Food and Fluid Intake. New York: Plenum Press, 1990: 183-206. Vol. 10.
17. Bray GA, Campfield LA. Metabolic factors in the control of energy stores. Metabolism 1975; 24: 99-117.
18. Campfield LA, Smith FJ, Rosenbaum M, Hirsch J. Human eating: Evidence for a physiological basis using a modified paradigm. Neurosci. Biobehav. Rev. 1996; 20: 133-137.
19. Grill HJ, Norgren R. The taste reactivity test. II: Mimetic responses to gustatory stimuli in chronic thalamic and chronic decerebrate rats. Brain Res. 1978; 143: 281-297.
20. Keesey RE. Physiological regulation of body weight and the issue of obesity. Med. Clin. N. Am. 1989; 73: 15-27.
21. Hill JO, Douglas HJ, Peters JC. Physical activity, fitness, and moderate obesity. In: Bouchard C, Shepard RJ, Stephens T, editors. Physical Activity, Fitness, and Health: International Proceedings and Consensus Statement. Human Kinetics Publisher Inc., 1994.
22. Hetherington AW, Ranson SW. The spontaneous activity and food intake of rats with hypothalamic lesions. Am. J. Physiol. 1942; 136: 609-617.
23. Smith FJ, Campfield LA. Pancreatic adaptation in VMH obesity: In vivo compensatory responses to altered neural input. Am. J. Physiol. (Regul. Int. Comp. Physiol. 20) 1986; 251: R70-R76.
24. West DB, York B, Waguespack J, Goudey-Lefevre J, Price AR. Genetics of dietary obesity in AKR/J × SWR/J mice: segregation of the trait and identification of a linked locus on chromosome 4. Mammalian Genome 1994; 5: 546-552.
25. Friedman JM, Leibel RL. Tackling a weighty problem. Cell 1992; 69: 217-220.
26. Friedman JM, Leibel RL, Siegel DS, Walsh J, Bahary N. Molecular mapping of the mouse ob mutation. Genomics 1991; 11: 1054-1062.
27. Bray GA, York DA. Hypothalamic and genetic obesity in experimental animals: an automonic and endocrine hypothesis. Physiol. Rev. 1979; 59: 719-809.
28. Truett GE, Bahary N, Friedman JM, Leibel RL. Rat obesity gene fatty (fa) maps to chromosomes: evidence for homology with mouse gene diabetes (db). Proc. Nat. Acad. Sci., USA 1991; 88: 7806-7809.
29. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-431.
30. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards JG, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor (OB-R). Cell 1995; 83: 1263-1271.
31. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RF, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84: 491-495.
32. Lee G, Proenca R, Montez JM, Carrol KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-635.
33. Chua SC, Chung WK, Wu-Peng XS, Zhang Y, Liu S-M, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994-996.
34. Bultman S, Michaud E, Woychik R. Molecular characterization of the mouse agouti locus. Cell 1992; 71: 1195-1204.
35. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkinson WO, Cone RD. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994; 371: 799-802.
36. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Melanocortinergic inhibition of feeding behavior and disruption with an agouti-mimetic. Nature 1997; 385: 165-168.
37. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141.
38. Naggert J, Fricker L, Varlamov O, Nishina P, Rouille Y, Steiner D, Carrol R, Paigen B, Leiter E. Hyperproinsulinemia in obese fat/fat mice associated with carboxypepidase E mutation which reduces enzyme activity. Nature Genetics 1995; 10: 134-142.
39. Noben-Trauth K, Naggert J, North M, Nishina P. A candidate for the mouse mutation tubby. Nature 1996; 380: 534-538.
40. Kleyn PW, Fan W, Kovats SG, Lee JJ, Pulido JC, Wu Y, Berkemeier LR, Misumi DJ, Holmgren L, Charlat O, Woolf EA, Tayber O, Brody T, P.Shu, Hawkins F, Kennedy B, Baldini L, Ebeling C, Alperin GD, Deeds J, Lakey ND, Culpepper J, Chen H, Glucksmann-Kuis MA, Carlson GA, Duyk GM, Moore KJ. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 1996; 85: 281-290.
41. Coleman DL, Hummel KP. The influence of genetic background on the expression of the obese (ob) gene in the mouse. Diabetologia 1973; 9: 287-293.
42. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978; 14: 141-148.
43. Coleman DL. Inherited obesity-diabetes syndromes in the mouse. Prog. Clinical Biol. Res. 1981; 45: 145-158.
44. Herberg L, Coleman DL. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 1977; 26: 59-99.
45. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9: 294-298.
46. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, Rosato EL, Caro JF. Evidence against either a premature stop codon or the absence of obese mRNA in human obesity. J. Clin. Invest. 1995; 95: 2986-2988.
47. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: Measurement of plasma leptin and ob mRNA in obese and weight-reduced subjects. Nature Medicine 1995; 1: 1155-1161.
48. Takahashi M, Funahashi T, Shimomura I, Matsuzawa Y. Plasma leptin levels and body fat distribution. Horm. Metab. Res. 1996; 28: 751-752.
49. Wing RR, Sinha MK, Considine RV, Lang W, Caro JF. Relationship between weight loss and changes in serum leptin levels. Horm. Metab. Res. 1996; 28: 698-703.
50. Miell JP, Englaro P, Blum WF. Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm. Metab. Res. 1996; 28: 704-707.
51. Kiess W, Englaro P, Hanitsch S, Rascher W, Attanasio A, Blum WF. High leptin concentrations in serum of very obese children are further stimulated by dexamethasone. Horm. Metab. Res. 1996; 28: 708-710.
52. Brabant G, Horn R, Mayr B, von zur Muhlen A, Honegger J, Buchfelder M. Serum leptin levels following hypothalamic surgery. Horm. Metab. Res. 1996; 28: 728-731.
53. Iida M, Murakami T, Yamada M, Sci M, Kuwajima M, Mizuno A, Noma Y, Aono T, Shima K. Hyperleptinemia in chronic renal failure. Horm. Metab. Res. 1996; 28: 724-727.
54. Leal-Cerro A, Considine RV, Peino R, Benegas E, Astorga R, Casanueva FF, Dieguez C. Serum immunoreactiveleptin levels are increased in patients with Cushing's syndrome. Horm. Metab. Res. 1996; 28: 711-713.
55. Deuschle M, Blum WF, Englaro P, Schweiger U, Weber B, Pffaum C-D, Heuser I. Plasma leptin in depressed patients and healthy controls. Horm. Metab. Res. 1996; 28: 714-717.
56. Bauman WA, Spungen AM, ZhongY-G, Mobbs CA. Plasma leptin is directly related to body adiposity in subjects with spinal cord injury. Horm. Metab. Res. 1996; 28: 732-736.
57. Scholz Gh, Englaro P, Thiele I, Scholz M, Klusmann T, Kellner K, Scherbaum WA, Rascher W, Blum WF. Dissociation of serum leptin concentration and body fat content during long term dietary intervention in obese individals. Horm. Metab. Res. 1996; 28: 718-723.
58. Saris WHM, Kempen KR, Campfield LA, Tenenbaum R. Responses of plasma OB protein concentration to weight cycling in obese woman. Obesity Res. 1996; 4: 40s.
59. Pasman WJ, Saris WHM. The relation of insulin and OB protein in trained and control, weight-reduced males. Obesity Res. 1996; 4: 14s.
60. Gougeon R, Campfield LA, Morais JA, Tenenbaum R, Marliss EB. Insulin treatment partially corrects the decreased OB protein levels in obese, type II diabetic subjects. Obesity Res. 1996; 4: 15s.
61. Morais JA, Ross R, Campfield LA, Gougeon R, Tenenbaum R, Marliss EB. OB protein levels are highly correlated to MRI-defined adipose tissue (AT) depots in healthy, non-obese young and elderly adults. Obesity Res. 1996; 4: 43s.
62. Montzoros CS, Flier JS, Logol AD. A longitudinal assessment of hormonal and physical alterations during puberty in boys: rising leptin levels may signal the onset of puberty. J. Clin. Endocr. Metab. 1997; in press.
63. Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, Becker GW, Bowsher RR, Stephens TW, Caro JF. Evidence of free and bound leptin in human circulation: studies in lean and obese subjects and during short-term fasting. J. Clin. Invest. 1996; 98: 1277-1282.
64. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D, Jr. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Medicine 1996; 2: 589-593.
65. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang P-L, Sinha MK, Considine RV. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
66. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17: 305-311.
67. Golden PL, Maccagnan TJ, Pardridge WM. Human blood-brain barrier leptin receptor: binding and endocytosis in isolated human brain microvessels. J. Clin. Invest. 1997; 99: 14-18.
68. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D, Jr. Insulin and the central regulation of energy balance: Update 1994. Endocr. Rev. 1994; 2: 109-113.
69. Schwartz MW, Marks J, Sipols AJ, Baskin DB, Woods SC, Kahn SE, Porte D, Jr. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 1991; 128: 2645-2647.
70. Giacobino J-P. Role of the beta3-adrenoceptor in the control of leptin expression. Norm. Metab. Res. 1996; 28: 633-637.
71. Saladin R, Staels B, Auwerx J, Briggs M. Regulation of obgene expression in rodents and humans. Norm. Metab. Res. 1996; 28: 638-641.
72. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
73. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. OB protein: A peripheral signal linking adiposity and central neural networks. Appetite 1996; 26: 302.
74. Pelleymounter M, Cullen M, Baker M, Hecht R, Winters D, Bone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
75. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
76. Rentsch J, Levens N, Chiesi M. Recombinant ob-gene product reduces food intake in fasted mice. Biochem. Biophys. Res. Commun. 1995; 214: 131-136.
77. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Jr., Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45: 531-535.
78. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKeller W, Rosteck PR, Jr., Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-532.
79. Levin N, Nelson C, Gurney A, Vandlen R, DeSauvage F. Decreased food intake does not completely account for adiposity reduction after OB protein infusion. Proc. Nat. Acad. Sci. USA 1996; 93: 1726-1730.
80. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuiper JL. Recombinant OB protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 1995; 96: 2065-2070.
81. van Dijk G, Theile TE, Donahey JCK, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, Seeley RJ. Central infusion of leptin and GLP-1(7-36) amide differentially stimulate c-FLI in the rat brain. Am. J. Physiol. 1996; 271: R1096-R1100.
82. Seeley RJ, van Dijk G, Campfield LA, Smith FJ, Burn P, Nelligan JA, Bell MS, Baskin DG, Woods SC, Schwartz MW. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm. Metab. Res. 1996; 28: 664-668.
83. Thiele TE, van Dijk G, Campfield LA, Smith FJ, Burn P, Woods SC, Bernstein IL, Seeley RJ. Central infusion of GLP-1, but not leptin, produces conditioned taste aversion in rats. Am. J. Physiol. 1997; in press.
84. Rohner-Jeanrenaud F, Cusin I, Sainsbury A, Zakrzewska K, Jeanrenaud B. Neuropeptide Y and leptin in lean and genetically obese fa/fa rats. Horm. Metab. Res. 1996; 28: 642-648.
85. Lin L, Truett GE, Levans N, York DA. Central, but not peripheral administration of leptin reduced the food intake and body weight in Zucker fatty and lean rats. Obesity Res. 1996; 4: 1s.
86. Devos R, Richards JG, Campfield LA, Tartaglia LA, Guisez Y, Van der Heyden J, Travernier J, Plaetinck G, Burn P. OB protein binds specifically to the choriod plexus of mice and rats. Proc. Nat. Acad. Sci. USA 1996; 93: 5668-5673.
87. Lynn RB, Cao GY, Considine RV, Hyde TM, Caro JF. Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice. Biochem. Biophys. Res. Commun. 1996; 219: 884-889.
88. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 1996; 387: 113-116.
89. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 1996; 98: 1101-1106.
90. Tartaglia LA. The leptin receptor. J. Biol. Chem. 1997; 272: 6093.
91. White DW, Tartaglia LA. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine & Growth Factors Reviews 1997. In press.
92. Frankish HM, Dryden S, Hopkins D, Wang Q, Williams G. Neuropeptide Y, the hypothalamus, and diabetes: Insights into the central control of metabolism. Peptides 1995; 16: 757-771.
93. Rohner-Jeanrenaud F, Jeanrenaud B. Obesity, leptin, and the brain. N. Engl. J. Med. 1996; 334: 324-325.
94. Ezzell C. Fat times for obesity research: Tons of new information, but how does it all fit together. J. NIH Res. 1995; 7: 39-45.
95. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptide 1986; 7: 189-192.
96. Smith FJ, Campfield LA, Moschera JA, Bailon P, Burn P. Feeding inhibition by neuropeptide Y. Nature 1996; 382: 307.
97. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996; 381: 415-418.
98. Stricker-Krongrad A, Chiesi M, Cumin F, Spanka C, Whitesbread S, Rentsch J, Lollman B, Hofbauer KG, Levens N. Interactions between leptin and neuropeptide Y in the control of food intake in the rat. Obesity Res. 1996; 4: 37s.
99. Erickson JC, Hollopetter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996; 274: 1704-1707.
100. Ahima RS, Prabakaren D, Mantzoros C, Ou D, Lowell B, Maratzoros-Flier E, Flier J. Role of leptin in the neuroendocrine responses to fasting. Nature 1996; 382: 250-252.
101. Chehab F, Lim M, Lu R. Correction of the sterility defect in homozygous obese female by treatment with human recombinant leptin. Nature Genetics 1996; 12: 318-320.
102. Glaum SR, Hara M, Bindokas V, Lee C, Polonsky K, Bell G, Miller R. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol. Pharmacol. 1996; 50: 230-235.